| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |